HO
Hologic
HOLX · NASDAQ
$76.01 +0.00% (+$0.00)
Market Cap $17.0B
P/E Ratio 30.65x
Div. Yield -
ROE 11.74%
Bulios Fair Price
$62.32
18.0% downside
Current Price
$76.01
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HOLX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
50 /100
Fair P/FCF 18.08x
P/E 30.65x
P/B 3.36x
Growth
34 /100
Stable FCF growth 6.77%
EPS growth 24.25%
Book val. growth 22.86%
Profitability
88 /100
Strong Op. margin 17.42%
Gross margin 53.01%
FCF margin 22.89%
Quality
47 /100
Average ROA 6.28%
ROIC 7.35%
Asset turnover 0.45x
Debt
89 /100
Low Int. coverage 7.95x
Debt/Equity 0.52x
Net debt/EBITDA 0.62x
Stability
47 /100
Moderate EPS volatility 70.31%
Beta 0.70x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HOLX
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Paul Malenchini
Employees
7,063
Headquarters
Marlborough